(Q40256942)

18 September 2017

title

A high-throughput drug screening system for HIV-1 transcription inhibitors (English)

1 reference

18 September 2017

0 references

4

Olaf Kutsch

1 reference

18 September 2017

1

Mirjam-Colette Kempf

1 reference

18 September 2017

Jennifer Jones

2

1 reference

18 September 2017

Marintha L Heil

series ordinal

3

1 reference

18 September 2017

publication date

10 July 2006

1 reference

Journal of Biomolecular Screening

18 September 2017

published in

1 reference

18 September 2017

volume

11

1 reference

18 September 2017

issue

7

1 reference

18 September 2017

page(s)

807-815

1 reference

Transcriptional but not translational regulation of HIV-1 by the tat gene product.

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290292

An inducible transcription factor activates expression of human immunodeficiency virus in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290292

HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290292

A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290292

Identification of multiple cyclin subunits of human P-TEFb

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290292

TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290292

Electron paramagnetic resonance dynamic signatures of TAR RNA-small molecule complexes provide insight into RNA structure and recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290292

Oligonucleotide inhibition of the interaction of HIV-1 Tat protein with the trans-activation responsive region (TAR) of HIV RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290292

Binding of Hoechst 33258 to the TAR RNA of HIV-1. Recognition of a pyrimidine bulge-dependent structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290292

The binding mode of drugs to the TAR RNA of HIV-1 studied by electric linear dichroism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290292

A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290292

Structural rearrangements of HIV-1 Tat-responsive RNA upon binding of neomycin B

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290292

Molecular dynamics studies of the HIV-1 TAR and its complex with argininamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290292

NMR evidence for a base triple in the HIV-2 TAR C-G.C+ mutant-argininamide complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290292

Solution structure of the HIV-2 TAR-argininamide complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290292

The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290292

Inhibition of type 1 human immunodeficiency virus replication by a tat antagonist to which the virus remains sensitive after prolonged exposure in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290292

A randomized trial of the activity and safety of Ro 24-7429 (Tat antagonist) versus nucleoside for human immunodeficiency virus infection. The AIDS Clinical Trials Group 213 Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290292

Viral dynamics and anti-viral pharmacodynamics: rethinking in vitro measures of drug potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290292

Bis-anthracycline antibiotics inhibit human immunodeficiency virus type 1 transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290292

Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290292

Viral dynamics in human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290292

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290292

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290292

T-cell line for HIV drug screening using EGFP as a quantitative marker of HIV-1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290292

21 January 2018

Identifiers

DOI

10.1177/1087057106290292

1 reference

18 September 2017

1 reference